- Home
- BMY vs HCA Comparison
BMY vs HCA Comparison
Compare BMY & HCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMY | HCA |
|---|---|---|
| Founded | 1887 | 1968 |
| Country | United States | United States |
| Employees | 32500 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.5B | 105.5B |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | BMY | HCA |
|---|---|---|
| Price | $64.72 | $413.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 20 |
| Target Price | $61.73 | ★ $511.84 |
| AVG Volume (30 Days) | ★ 12.4M | 1.7M |
| Earning Date | 04-30-2026 | 04-24-2026 |
| Dividend Yield | ★ 4.38% | 0.72% |
| EPS Growth | N/A | ★ 28.77 |
| EPS | N/A | ★ 7.15 |
| Revenue | N/A | ★ $75,600,000,000.00 |
| Revenue This Year | N/A | $5.11 |
| Revenue Next Year | N/A | $4.86 |
| P/E Ratio | ★ $17.26 | $57.19 |
| Revenue Growth | N/A | ★ 7.08 |
| 52 Week Low | $42.52 | $353.99 |
| 52 Week High | $68.10 | $556.52 |
Technical Indicators
Market Signals| Indicator | BMY | HCA |
|---|---|---|
| Relative Strength Index (RSI) | 61.95 | 56.47 |
| Support Level | $53.81 | $355.44 |
| Resistance Level | N/A | $425.43 |
| Average True Range (ATR) | 1.86 | 12.39 |
| MACD | 0.14 | 2.69 |
| Stochastic Oscillator | 52.41 | 77.34 |
Price Performance
Historical ComparisonAbout BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About HCA HCA Healthcare Inc.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.